APIX Biosciences
0771.667.563 · rovalta.com · 24/09/2026
APIX Biosciences
Overview
What does APIX Biosciences do?
APIX Biosciences is a Public limited company incorporated in 2021. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Wingene. It employs on average 4,0 ETP workers (FTE).
8750 Wingene · FlandreSee on map
Joint committees (4)
- 116
- 1160
- 207
- 2070
Trend over 4 financial years
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | -149,1 k € | -145% | 332,3 k € | +943% | 31,9 k € | +184% | -38 k € |
| EBITDA | -578,4 k € | -477% | -100,2 k € | -40.3% | -71,4 k € | -86.4% | -38,3 k € |
| Operating result | -680,6 k € | -285% | -176,7 k € | -62.9% | -108,5 k € | -86.5% | -58,2 k € |
| Net result | -621 k € | -549% | -95,7 k € | -7.8% | -88,8 k € | -274% | -23,8 k € |
| Balance sheet | |||||||
| Equity | 1,1 M € | -36.6% | 1,7 M € | -5.3% | 1,8 M € | +51.7% | 1,2 M € |
| Total assets | 5,9 M € | +8.9% | 5,4 M € | +88.3% | 2,9 M € | +59.6% | 1,8 M € |
| Cash | 430,5 k € | +1613% | 25,1 k € | -97.1% | 877,1 k € | +154% | 345 k € |
| Debts | 4,8 M € | +30.0% | 3,7 M € | +242% | 1,1 M € | +89.4% | 570 k € |
| Other | |||||||
| Workforce | 4,0 ETP | +5.3% | 3,8 ETP | +322% | 0,9 ETP | – | |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 30/04/2025 · 5 active · 8 ended
Other companies at this address
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Micro model |
| Start of the financial year | 01/05/2024 | 01/05/2023 | 01/05/2022 | 23/07/2021 |
| Closing of the financial year | 30/04/2025 | 30/04/2024 | 30/04/2023 | 30/04/2022 |
| Length of the financial year | 12 months | 12 months | 12 months | 10 months |
| Filing date | 28/11/2025 | 29/11/2024 | 22/12/2023 | 30/11/2022 |
| General meeting | 19/09/2025 | 31/10/2024 | 18/12/2023 | 31/10/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
4 filings with the NBB
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 30/04/2025 · 5 active · 8 ended
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Other27/11/2025DIVERSEN
- Mandates20/11/2025ONTSLAGEN - BENOEMINGEN
- Mandates18/07/2025KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Capital / shares17/06/2025KAPITAAL - AANDELEN
- Mandates09/04/2024ONTSLAGEN - BENOEMINGEN
- Other23/01/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Capital / shares07/09/2022KAPITAAL - AANDELEN
- Mandates21/06/2022ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-621 k €↓
- 2024Annual accounts 2024-95,7 k €↓
- 2023Annual accounts 2023-88,8 k €↓
- 2022Annual accounts 2022-23,8 k €
- 23/07/2021IncorporationPublic limited company